Literature DB >> 22093444

Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells.

Jasmin Batliner1, Emanuel Buehrer, Martin F Fey, Mario P Tschan.   

Abstract

MicroRNAs can influence hematopoietic cell lineage commitment and aberrant expression of hematopoietic miRNAs contributes to AML pathology. We found that miR-143 and miR-145 expression is significantly repressed in primary AML patient samples as compared to neutrophils of healthy donors. Further analysis revealed impaired neutrophil differentiation of APL cells upon inhibition of miR-145 expression. Lastly, we identified p73 as transcriptional regulator of miR-143/145 during neutrophil differentiation of APL cells. Our data suggest that low miR-145 levels in APL, possibly due to aberrant expression of p73 transcription factors, contribute to the differentiation block seen in this disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22093444     DOI: 10.1016/j.leukres.2011.10.006

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

1.  miR Cluster 143/145 Directly Targets Nrl and Regulates Rod Photoreceptor Development.

Authors:  Sreekumaran Sreekanth; Vazhanthodi A Rasheed; Lalitha Soundararajan; Jayesh Antony; Minakshi Saikia; Krishnankutty Chandrika Sivakumar; Ani V Das
Journal:  Mol Neurobiol       Date:  2016-11-23       Impact factor: 5.590

2.  Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cells.

Authors:  Julian Wampfler; Elena A Federzoni; Bruce E Torbett; Martin F Fey; Mario P Tschan
Journal:  J Leukoc Biol       Date:  2015-05-19       Impact factor: 4.962

Review 3.  The regulatory role of serum response factor pathway in neutrophil inflammatory response.

Authors:  Ashley Taylor; Stephanie Halene
Journal:  Curr Opin Hematol       Date:  2015-01       Impact factor: 3.284

4.  Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C/EBPα-miRNA-223 axis.

Authors:  Ruixue Ren; Yong He; Dong Ding; Aoyuan Cui; Huarui Bao; Jing Ma; Xin Hou; Yu Li; Dechun Feng; Xiaoling Li; Suthat Liangpunsakul; Bin Gao; Hua Wang
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

5.  Acute pyelonephritis in renal allografts: a new role for microRNAs?

Authors:  Steve Oghumu; Anna Bracewell; Uday Nori; Kirsteen H Maclean; Joan-Miquel Balada-Lasat; Sergey Brodsky; Ronald Pelletier; Mitchell Henry; Abhay R Satoskar; Tibor Nadasdy; Anjali A Satoskar
Journal:  Transplantation       Date:  2014-03-15       Impact factor: 4.939

6.  SRF is required for neutrophil migration in response to inflammation.

Authors:  Ashley Taylor; Wenwen Tang; Emanuela M Bruscia; Ping-Xia Zhang; Aiping Lin; Peter Gaines; Dianqing Wu; Stephanie Halene
Journal:  Blood       Date:  2014-02-26       Impact factor: 22.113

7.  microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

8.  Differential expression of miR-145 in children with Kawasaki disease.

Authors:  Chisato Shimizu; Jihoon Kim; Petra Stepanowsky; Christine Trinh; Hubert D Lau; Johnny C Akers; Clark Chen; John T Kanegaye; Adriana Tremoulet; Lucila Ohno-Machado; Jane C Burns
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

9.  Identification of β-Dystrobrevin as a Direct Target of miR-143: Involvement in Early Stages of Neural Differentiation.

Authors:  Maria Teresa Quaranta; Isabella Spinello; Rosa Paolillo; Gianfranco Macchia; Alessandra Boe; Marina Ceccarini; Catherine Labbaye; Pompeo Macioce
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

10.  Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.

Authors:  Amr Rafat Elhamamsy; Muhammad Suleiman El Sharkawy; Ahmed Farouk Zanaty; Mohammed Ahmed Mahrous; Ahmed Ezzat Mohamed; Eslam Ahmed Abushaaban
Journal:  Int J Mol Cell Med       Date:  2017-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.